Recent Investment and Ecosystem Highlights India’s biotech startup ecosystem is moving beyond early-stage experimentation into a phase of strategic innovation and scalable commercial ventur...
Latest Developments on API Self-Reliance India has long been recognized as the “pharmacy of the world,” supplying affordable generic medicines to countries across the globe. However, despite its...
Recent Industry Context Clinical trials have always been a crucial pillar of healthcare innovation, acting as the bridge between breakthrough science and real-world patient benefit. In recent ye...
Latest Developments in Global Pharma Supply Chains The COVID-19 pandemic exposed critical vulnerabilities in global pharmaceutical supply chains, highlighting the risks associated with overrelia...
Latest Developments in Rare Disease Policy Rare diseases collectively affect millions of patients worldwide, yet each individual condition impacts a relatively small population. Historically, li...
Latest Developments in the Biosimilar Market The global pharmaceutical industry is witnessing rapid growth in the biosimilars market as patents for several blockbuster biologic drugs begin to ex...
Latest Developments on GLP-1 Therapies In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as one of the fastest-growing segments in the global pharmaceutical market....
Latest Developments in Women Leadership in Pharma India’s pharmaceutical industry has long been recognized for its scientific talent, manufacturing capabilities, and global influence in generic ...
Emerging Technology Trends in Biopharma The intersection of technology and biopharma isn’t a futuristic idea anymore it’s happening right now. Artificial intelligence (...
Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarksgrove right at the coast of the Semantics, a large ...